Metformin for liver cancer prevention in patients with type 2 diabetes: a systematic review and meta-analysis.

@article{Zhang2012MetforminFL,
  title={Metformin for liver cancer prevention in patients with type 2 diabetes: a systematic review and meta-analysis.},
  author={Zhi-Jiang Zhang and Zhi-Jie Zheng and Rong Shi and Qing Su and Qingwu Jiang and Kevin Kip},
  journal={The Journal of clinical endocrinology and metabolism},
  year={2012},
  volume={97 7},
  pages={
          2347-53
        }
}
CONTEXT Data on the potential effect of metformin on the risk of liver cancer are limited and inconsistent. OBJECTIVE The objective of this study was to review the evidence currently available to examine the potential role of metformin in chemoprevention for liver cancer in patients with type 2 diabetes. DATA SOURCES The data sources of the study included the PubMed and SciVerse Scopus databases. STUDY SELECTION Selection included studies that assessed the effect of metformin therapy on… CONTINUE READING
BETA

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 92 CITATIONS, ESTIMATED 60% COVERAGE

Low concentration of metformin induces a p53-dependent senescence in hepatoma cells via activation of the AMPK pathway.

  • International journal of oncology
  • 2013
VIEW 11 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Diabetes mellitus may worsen the prognosis in hepatocellular carcinoma patients undergoing curative microwave ablation.

  • Journal of B.U.ON. : official journal of the Balkan Union of Oncology
  • 2018
VIEW 1 EXCERPT

Gastrointestinal Complications of Diabetes

Marija Duvnjak, Lea Smir
  • Clinical Gastroenterology
  • 2018

FILTER CITATIONS BY YEAR

2012
2019

CITATION STATISTICS

  • 1 Highly Influenced Citations

  • Averaged 9 Citations per year from 2017 through 2019